IVF
Price
$0.82
Change
-$0.02 (-2.38%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
3.68M
RANI
Price
$0.49
Change
+$0.03 (+6.52%)
Updated
Sep 5, 02:18 PM (EDT)
Capitalization
22.03M
68 days until earnings call
Interact to see
Advertisement

IVF vs RANI

Header iconIVF vs RANI Comparison
Open Charts IVF vs RANIBanner chart's image
INVO Fertility
Price$0.82
Change-$0.02 (-2.38%)
Volume$100
Capitalization3.68M
Rani Therapeutics Holdings
Price$0.49
Change+$0.03 (+6.52%)
Volume$150
Capitalization22.03M
IVF vs RANI Comparison Chart in %
Loading...
IVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVF vs. RANI commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVF is a Hold and RANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (IVF: $0.84 vs. RANI: $0.46)
Brand notoriety: IVF and RANI are both not notable
IVF represents the Medical/Nursing Services, while RANI is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVF: 15% vs. RANI: 32%
Market capitalization -- IVF: $3.68M vs. RANI: $22.03M
IVF [@Medical/Nursing Services] is valued at $3.68M. RANI’s [@Biotechnology] market capitalization is $22.03M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVF’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • IVF’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, IVF is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVF’s TA Score shows that 3 TA indicator(s) are bullish while RANI’s TA Score has 5 bullish TA indicator(s).

  • IVF’s TA Score: 3 bullish, 3 bearish.
  • RANI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RANI is a better buy in the short-term than IVF.

Price Growth

IVF (@Medical/Nursing Services) experienced а -11.35% price change this week, while RANI (@Biotechnology) price change was -14.78% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.21%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +24.78%.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

RANI is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.21% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RANI($22M) has a higher market cap than IVF($3.68M). IVF (-65.288) and RANI (-66.423) have similar YTD gains . IVF has higher annual earnings (EBITDA): -8.08M vs. RANI (-47.11M). RANI has more cash in the bank: 10.2M vs. IVF (549K). IVF has less debt than RANI: IVF (7.13M) vs RANI (21.6M). IVF has higher revenues than RANI: IVF (6.62M) vs RANI (1.2M).
IVFRANIIVF / RANI
Capitalization3.68M22M17%
EBITDA-8.08M-47.11M17%
Gain YTD-65.288-66.42398%
P/E RatioN/AN/A-
Revenue6.62M1.2M552%
Total Cash549K10.2M5%
Total Debt7.13M21.6M33%
FUNDAMENTALS RATINGS
IVF: Fundamental Ratings
IVF
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
37
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IVFRANI
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BENF0.400.02
+4.39%
Beneficient
NCLH25.590.25
+0.99%
Norwegian Cruise Line Holdings Ltd
GEL16.690.03
+0.18%
Genesis Energy LP
TALK2.63-0.02
-0.75%
Talkspace
CVM11.24-0.59
-4.99%
Cel-Sci Corp

IVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVF has been loosely correlated with MGRM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IVF jumps, then MGRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVF
1D Price
Change %
IVF100%
-9.30%
MGRM - IVF
39%
Loosely correlated
-1.16%
ADTX - IVF
31%
Poorly correlated
-5.64%
ISPC - IVF
30%
Poorly correlated
-0.25%
HYPR - IVF
29%
Poorly correlated
N/A
RANI - IVF
28%
Poorly correlated
-5.23%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-5.23%
XENE - RANI
37%
Loosely correlated
-0.49%
ADVM - RANI
33%
Loosely correlated
-2.46%
VYGR - RANI
33%
Loosely correlated
+5.43%
VNDA - RANI
33%
Poorly correlated
-1.69%
OCUL - RANI
30%
Poorly correlated
-1.85%
More